(HST) Host Hotels & Resorts - Ratings and Ratios
Luxury Hotels, Upper-Upscale Hotels, Lodging REIT
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 5.15% |
| Yield on Cost 5y | 8.00% |
| Yield CAGR 5y | 21.47% |
| Payout Consistency | 67.3% |
| Payout Ratio | 90.5% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 24.5% |
| Value at Risk 5%th | 38.6% |
| Relative Tail Risk | -4.29% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.48 |
| Alpha | -4.95 |
| CAGR/Max DD | 0.23 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.404 |
| Beta | 1.016 |
| Beta Downside | 0.828 |
| Drawdowns 3y | |
|---|---|
| Max DD | 36.03% |
| Mean DD | 12.90% |
| Median DD | 13.33% |
Description: HST Host Hotels & Resorts January 02, 2026
Host Hotels & Resorts (NASDAQ:HST) is the largest lodging REIT in the S&P 500, owning 74 U.S. hotels and five international properties-about 42,500 rooms-plus non-controlling stakes in seven domestic joint ventures. The portfolio is anchored by premium brands such as Marriott, Ritz-Carlton, Hyatt, Hilton, Four Seasons and independent upscale concepts.
Recent performance metrics show FY 2023 adjusted FFO of $1.12 per share and an occupancy rate of roughly 78% across the portfolio, with RevPAR up 5% YoY, reflecting a rebound in both leisure and business travel. The company maintains a net debt-to-EBITDA ratio near 4.5×, indicating moderate leverage relative to peers.
Key economic drivers for HST include discretionary consumer spending, corporate travel recovery, and the trajectory of interest rates, which affect REIT financing costs. A sector-wide trend toward upscale and luxury experiences is bolstering rental rates, while supply constraints in prime urban markets support occupancy stability.
For a deeper quantitative comparison of HST’s valuation metrics, you may find ValueRay’s platform useful.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (738.0m TTM) > 0 and > 6% of Revenue (6% = 356.3m TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA -1.88pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -5.46% (prev -6.40%; Δ 0.94pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.10 (>3.0%) and CFO 1.30b > Net Income 738.0m (YES >=105%, WARN >=100%) |
| Net Debt (5.10b) to EBITDA (1.79b) ratio: 2.84 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.75 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (693.9m) change vs 12m ago -1.70% (target <= -2.0% for YES) |
| Gross Margin 53.34% (prev 53.24%; Δ 0.11pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 45.47% (prev 42.65%; Δ 2.82pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.32 (EBITDA TTM 1.79b / Interest Expense TTM 234.0m) >= 6 (WARN >= 3) |
Altman Z'' 0.11
| (A) -0.02 = (Total Current Assets 991.0m - Total Current Liabilities 1.31b) / Total Assets 13.04b |
| (B) -0.04 = Retained Earnings (Balance) -563.0m / Total Assets 13.04b |
| (C) 0.08 = EBIT TTM 1.01b / Avg Total Assets 13.06b |
| (D) -0.10 = Book Value of Equity -623.0m / Total Liabilities 6.23b |
| Total Rating: 0.11 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 62.82
| 1. Piotroski 5.0pt |
| 2. FCF Yield 3.78% |
| 3. FCF Margin 11.30% |
| 4. Debt/Equity 0.85 |
| 5. Debt/Ebitda 2.84 |
| 6. ROIC - WACC (= 1.18)% |
| 7. RoE 11.12% |
| 8. Rev. Trend 73.70% |
| 9. EPS Trend -8.85% |
What is the price of HST shares?
Over the past week, the price has changed by +1.54%, over one month by +7.73%, over three months by +16.12% and over the past year by +14.38%.
Is HST a buy, sell or hold?
- Strong Buy: 10
- Buy: 3
- Hold: 6
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the HST price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 19.8 | 7.3% |
| Analysts Target Price | 19.8 | 7.3% |
| ValueRay Target Price | 20.7 | 12% |
HST Fundamental Data Overview January 06, 2026
P/E Forward = 19.5313
P/S = 2.126
P/B = 1.8749
P/EG = 2.223
Beta = 1.199
Revenue TTM = 5.94b USD
EBIT TTM = 1.01b USD
EBITDA TTM = 1.79b USD
Long Term Debt = 4.08b USD (from longTermDebt, last quarter)
Short Term Debt = 995.0m USD (from shortTermDebt, last quarter)
Debt = 5.64b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.10b USD (from netDebt column, last quarter)
Enterprise Value = 17.75b USD (12.65b + Debt 5.64b - CCE 539.0m)
Interest Coverage Ratio = 4.32 (Ebit TTM 1.01b / Interest Expense TTM 234.0m)
EV/FCF = 26.46x (Enterprise Value 17.75b / FCF TTM 671.0m)
FCF Yield = 3.78% (FCF TTM 671.0m / Enterprise Value 17.75b)
FCF Margin = 11.30% (FCF TTM 671.0m / Revenue TTM 5.94b)
Net Margin = 12.43% (Net Income TTM 738.0m / Revenue TTM 5.94b)
Gross Margin = 53.34% ((Revenue TTM 5.94b - Cost of Revenue TTM 2.77b) / Revenue TTM)
Gross Margin QoQ = 50.79% (prev 54.41%)
Tobins Q-Ratio = 1.36 (Enterprise Value 17.75b / Total Assets 13.04b)
Interest Expense / Debt = 1.06% (Interest Expense 60.0m / Debt 5.64b)
Taxrate = 5.23% (9.00m / 172.0m)
NOPAT = 958.1m (EBIT 1.01b * (1 - 5.23%))
Current Ratio = 0.75 (Total Current Assets 991.0m / Total Current Liabilities 1.31b)
Debt / Equity = 0.85 (Debt 5.64b / totalStockholderEquity, last quarter 6.66b)
Debt / EBITDA = 2.84 (Net Debt 5.10b / EBITDA 1.79b)
Debt / FCF = 7.61 (Net Debt 5.10b / FCF TTM 671.0m)
Total Stockholder Equity = 6.64b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.65% (Net Income 738.0m / Total Assets 13.04b)
RoE = 11.12% (Net Income TTM 738.0m / Total Stockholder Equity 6.64b)
RoCE = 9.43% (EBIT 1.01b / Capital Employed (Equity 6.64b + L.T.Debt 4.08b))
RoIC = 8.17% (NOPAT 958.1m / Invested Capital 11.72b)
WACC = 6.99% (E(12.65b)/V(18.29b) * Re(9.66%) + D(5.64b)/V(18.29b) * Rd(1.06%) * (1-Tc(0.05)))
Discount Rate = 9.66% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.97%
[DCF Debug] Terminal Value 81.44% ; FCFF base≈770.2m ; Y1≈741.1m ; Y5≈726.5m
Fair Price DCF = 15.85 (EV 16.01b - Net Debt 5.10b = Equity 10.90b / Shares 687.7m; r=6.99% [WACC]; 5y FCF grow -5.06% → 2.90% )
EPS Correlation: -8.85 | EPS CAGR: -16.39% | SUE: 4.0 | # QB: 3
Revenue Correlation: 73.70 | Revenue CAGR: 7.98% | SUE: 0.98 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.33 | Chg30d=+0.035 | Revisions Net=+2 | Analysts=2
EPS next Year (2026-12-31): EPS=0.87 | Chg30d=+0.026 | Revisions Net=+4 | Growth EPS=-16.4% | Growth Revenue=+1.7%
Additional Sources for HST Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle